Clinical Trial Update: Cytoflavin in the Complex Rehabilitation of Stroke Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Cytoflavin for the complex rehabilitation of stroke patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cytoflavin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Stroke | Phase 3 | Status: COMPLETED